Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Immune Cell Traits and Aortic Dissection: A Mendelian Randomisation Study
Author(s): Tian-le Li , Mao-long Fu , Li-hong Wang , et al Added: 1 year ago

Electrophysiology & Arrhythmia

Inherited and Congenital Cardiac Conditions
Erratum: Causal Characteristics of Immune Cells
Author(s): Tian-le Li , Mao-long Fu , Li-hong Wang , et al Added: 11 months ago
Semaglutide May Aid Vascular Repair in High-Risk Patients
Added: 3 weeks ago Source:  Radcliffe CVRM
Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are known to reduce major atherosclerotic cardiovascular events, but the full extent of their mechanisms is still being explored. The SEMA-VR CardioLink-15 trial investigated whether semaglutide affects the levels of circulating vascular regenerative (VR) cells, which are involved in vessel repair and may modulate atherothrombotic risk.¹… View more

Cardiovascular Renal Metabolic
Cellular Senescence and Frailty
Author(s): Jorge D Erusalimsky Added: 1 week ago

Prevention & Chronic Conditions

CV Disease in Special Populations
Immune Cell Traits and Heart Failure: A Mendelian Randomisation Study
Author(s): Wei Gao , Hui Wang , Jian-long Wang , et al Added: 5 months ago

Demographic

Heart Failure
AF Symposium 26: STYLE AF Update
Author(s): Roland R Tilz Added: 1 month ago
AF Symposium 2026 - Prof Roland Tilz (University Heart Center Lübeck, DE) presents updated findings from the STYLE AF study evaluating vascular closure strategies in patients undergoing atrial fibrillation ablation, with implications for procedural efficiency and same-day discharge protocols.Results demonstrated clear superiority of the vascular closure device across multiple clinically relevant… View more

Electrophysiology & Arrhythmia
ACC 2025: The CardiAMP-HF Trial
Author(s): Amish Raval Added: 1 year ago
ACC 2025 - Principal results from autologous cell therapy in patients with heart failure with reduced ejection fraction (HFrEF) show favourable safety outcomes, however, the study did not meet its primary efficacy outcome using 6 minute walking rests as 3rd F-S tier.Dr Amish Raval (UW Health University Hospital Interventional Cardiology Clinic, WI, US) joins us onsite at ACC to discuss the… View more

Heart Failure
Author(s): Fatin Fazrina Roslan , Yuexin Yu , Nurul Ain Nasim Mohd Yusof , et al Added: 1 year ago

Anticoagulation
ESC HF 25: The FIVE-STAR Trial
Author(s): Added: 10 months ago
ESC HF 25 - FIVE-STAR primary outcome is neutral, though finerenone was shown to significantly reduce UACR rates with a 29% greater reduction compared to placebo.We are joined by Dr Atsushi Tanaka (Saga University, Saga, JP) to discuss the findings from FIVE-STAR, a randomized trial investigating the effects of finerenone on vascular stiffness and cardiorenal biomarkers in patients with type 2… View more

Cardiovascular Renal Metabolic
CRT 24: The ABSORB Trial
Author(s): David Power Added: 2 years ago
CRT 24 - We are joined in this short virtual interview by investigator, Dr David Power (Mount Sinai Hospital, US) to discuss the latest findings from the ABSORB trial series, revealed in 2024 at the CRT conference.ABSORB III is a prospective, randomized, single-blind, multicenter trail aiming to support the pre-market approval of the Absorb bioresorbable vascular scaffold (Abbott) for the… View more

Intervention

Vascular Disease and Surgery